FR2362129A1 - 9-hydroxyhexahydrobenzo(c)quinoleines et intermediaires de synthese - Google Patents

9-hydroxyhexahydrobenzo(c)quinoleines et intermediaires de synthese

Info

Publication number
FR2362129A1
FR2362129A1 FR7715049A FR7715049A FR2362129A1 FR 2362129 A1 FR2362129 A1 FR 2362129A1 FR 7715049 A FR7715049 A FR 7715049A FR 7715049 A FR7715049 A FR 7715049A FR 2362129 A1 FR2362129 A1 FR 2362129A1
Authority
FR
France
Prior art keywords
compounds
hydroxyhexahydrobenzo
quinoleins
acylated
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7715049A
Other languages
English (en)
French (fr)
Other versions
FR2362129B1 (ja
Inventor
Michael Ross Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2362129A1 publication Critical patent/FR2362129A1/fr
Application granted granted Critical
Publication of FR2362129B1 publication Critical patent/FR2362129B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7715049A 1976-05-17 1977-05-17 9-hydroxyhexahydrobenzo(c)quinoleines et intermediaires de synthese Granted FR2362129A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68733276A 1976-05-17 1976-05-17
US75361976A 1976-12-22 1976-12-22
US77792877A 1977-03-15 1977-03-15

Publications (2)

Publication Number Publication Date
FR2362129A1 true FR2362129A1 (fr) 1978-03-17
FR2362129B1 FR2362129B1 (ja) 1983-05-20

Family

ID=27418484

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7715049A Granted FR2362129A1 (fr) 1976-05-17 1977-05-17 9-hydroxyhexahydrobenzo(c)quinoleines et intermediaires de synthese
FR8003318A Granted FR2446284A1 (fr) 1976-05-17 1980-02-14 Tetrahydro-benzo(c)quinoleine-9(8h)ones

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8003318A Granted FR2446284A1 (fr) 1976-05-17 1980-02-14 Tetrahydro-benzo(c)quinoleine-9(8h)ones

Country Status (23)

Country Link
JP (1) JPS6016426B2 (ja)
AR (1) AR215896A1 (ja)
BG (4) BG27897A3 (ja)
CA (1) CA1095909A (ja)
CH (2) CH626881A5 (ja)
DD (1) DD130855A5 (ja)
DE (1) DE2722383A1 (ja)
DK (1) DK212677A (ja)
ES (4) ES458812A1 (ja)
FI (1) FI64141C (ja)
FR (2) FR2362129A1 (ja)
GR (1) GR74122B (ja)
IL (1) IL52087A (ja)
LU (1) LU77341A1 (ja)
NL (2) NL170141C (ja)
NO (1) NO147028C (ja)
NZ (1) NZ184114A (ja)
PH (1) PH16833A (ja)
PT (1) PT66550B (ja)
RO (1) RO76839A (ja)
SE (1) SE7704749L (ja)
SU (1) SU1098520A3 (ja)
YU (2) YU156882A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009386A1 (en) * 1978-09-22 1980-04-02 Pfizer Inc. 2,10-Disubstituted dibenzo(b,d)pyrans and benzo(c)quinolines and pharmaceutical compositions thereof
FR2537136A1 (fr) * 1982-12-03 1984-06-08 Chinoin Gyogyszer Es Vegyeszet Derives de dibenzo(bd)pyrane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802211A1 (de) * 1978-01-19 1979-07-26 Basf Ag N-substituierte 2,6-dialkylaniline und verfahren zur herstellung von n- substituierten 2,6-dialkylanilinen
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
CN105924386A (zh) * 2009-03-25 2016-09-07 Abbvie 公司 抗病毒化合物和其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2137720A1 (ja) * 1971-05-12 1972-12-29 Sharps Ass
US3856821A (en) * 1973-07-18 1974-12-24 Smithkline Corp ALKOXY DIBENZO (b,d) PYRANS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
US3944673A (en) * 1973-11-05 1976-03-16 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2137720A1 (ja) * 1971-05-12 1972-12-29 Sharps Ass
US3856821A (en) * 1973-07-18 1974-12-24 Smithkline Corp ALKOXY DIBENZO (b,d) PYRANS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/67 *
EXBK/68 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009386A1 (en) * 1978-09-22 1980-04-02 Pfizer Inc. 2,10-Disubstituted dibenzo(b,d)pyrans and benzo(c)quinolines and pharmaceutical compositions thereof
FR2537136A1 (fr) * 1982-12-03 1984-06-08 Chinoin Gyogyszer Es Vegyeszet Derives de dibenzo(bd)pyrane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NL170141C (nl) 1982-10-01
BG28415A4 (en) 1980-04-15
IL52087A0 (en) 1977-07-31
NO147028B (no) 1982-10-11
YU156882A (en) 1983-02-28
LU77341A1 (ja) 1977-12-13
BG28416A4 (en) 1980-04-15
FI64141B (fi) 1983-06-30
FR2446284B1 (ja) 1983-08-26
FI771550A (ja) 1977-11-18
ES458812A1 (es) 1978-08-16
NO147028C (no) 1983-01-19
NZ184114A (en) 1982-02-23
ES469202A1 (es) 1978-11-16
SU1098520A3 (ru) 1984-06-15
PT66550A (en) 1977-06-01
SE7704749L (sv) 1977-12-05
DK212677A (da) 1977-11-18
YU156982A (en) 1983-02-28
CH628034A5 (en) 1982-02-15
PH16833A (en) 1984-03-06
ES469204A1 (es) 1978-11-16
FI64141C (fi) 1983-10-10
AU2516277A (en) 1978-06-22
NL7705433A (nl) 1977-11-21
PT66550B (en) 1978-10-18
ES469203A1 (es) 1978-11-16
CH626881A5 (en) 1981-12-15
JPS6016426B2 (ja) 1985-04-25
FR2362129B1 (ja) 1983-05-20
FR2446284A1 (fr) 1980-08-08
BG28414A4 (en) 1980-04-15
DE2722383C2 (ja) 1990-06-07
BG27897A3 (en) 1980-01-15
GR74122B (ja) 1984-06-06
CA1095909A (en) 1981-02-17
RO76839A (ro) 1981-05-30
AR215896A1 (es) 1979-11-15
IL52087A (en) 1981-11-30
DD130855A5 (de) 1978-05-10
JPS52144672A (en) 1977-12-02
NO771738L (no) 1977-11-18
NL7804461A (nl) 1978-08-31
DE2722383A1 (de) 1977-12-01

Similar Documents

Publication Publication Date Title
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
FR2362129A1 (fr) 9-hydroxyhexahydrobenzo(c)quinoleines et intermediaires de synthese
IE41440L (en) Thiatetracyclines
BE847080A (fr) Procede d'attaque en deux stades des hemicelluloses de produits naturels renfermant du xylane en vue de la recuperation du xylose,
IE42977L (en) Triaryl-piperidine methanols.
FR2336412A1 (fr) Procede nouveau de synthese de la 3', 4'-didesoxykanamycine b''
FR2292040A1 (fr) Procede de production d'acide l-aspartique par fermentation d'hydrocarbure
BE855795A (fr) Procede de synthese d'anthracyclinones optiquement actives
FR2390954A1 (fr) Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant
GB1421580A (en) Production of benzylamine derivatives
FR2356658A1 (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
AR206208A1 (es) Derivados de acidos 4,4'-bis(1",3",5" triazinil-(2")-amino)estilbeno-2,2'-disulfonicos sustituidos
ES417164A1 (es) Procedimiento para la preparacion de cardenolid-3,2-desoxi-glicosidos.
ES416038A1 (es) Procedimiento para la preparacion de n - (heteroarilmetil)-7alfa-acil - 6,14 - endoeteno-tetrahidronororipavinas y te- bainas.
GB1415682A (en) Amides and thioamides
BE801006A (fr) Synthese de l'acide n(5)-methyltetrahydrohomofolique et autres derives hydrogenes de l'acide homofolique
BE764646A (fr) Procede de synthese de l'hydroperoxyde d'isopentane
FR2350341A1 (fr) Nouveaux derives de piperidine et leur methode de preparation
BE802345A (fr) Nouveau derive d'acide 1,4-dihydro-1-substitute-4-oxo-3-quinoleine-carboxylique
GB936366A (en) Methylsulphonyl-phenyl compounds
JPS52108908A (en) Preparation of n-substituted thiolcarbamates
ES449917A1 (es) Un procedimiento para la preparacion de acidos (1-oxo-2-arilo tienil-2-sustituido-5-indaniloxi (o tio)) alcanoicos.
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
IE40226L (en) 5-AMINOMETHYL-m-DIOXANES.
BE839634A (fr) Synthese de l'acide 3-benzoylhydratropique

Legal Events

Date Code Title Description
ST Notification of lapse